Does ezetimibe monotherapy improve lipid and lipoprotein levels in people with hypercholesterolaemia?
Ezetimibe monotherapy provides favorable short-term changes in lipid profiles for patients with hypercholesterolemia.
In a meta-analysis restricted to short-term trials in hypercholesterolaemia, significant potentially favourable changes in lipid and lipoprotein levels relative to baseline occurred with ezetimibe monotherapy. Further long-term studies with cardiovascular and other clinical outcome data are needed to assess the efficacy and safety of ezetimibe more fully.
Pandor et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: